Position in DFTX
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$1,276,712
New position
Shares Held
27,141
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#2
of 7 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 76.15784237868907.ToString("F0")%
Shared 0.ToString("F0")%
None 23.842157621310932.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026STABLEFORD CAPITAL II LLC holds $2,163,916 across 2 Biotechnology names. DFTX ranks #1 (59.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
This page
|
27,141 | $1,276,712 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
168,350 | $887,204 |
All Filings in DFTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,276,712 | 27,141 | Shares | Sole | 2026-07-06 | |
| No filing history on record for this holder in this stock. | ||||||